I agree that this site is using cookies. You can find further informations here.
X
Blagden, SP
22  results:
Search for persons X
?
1

Additional consensus recommendations for conducting complex..:

Blagden, SP ; Yu, L-M ; Ellis, S...
British Journal of Cancer.  , 2022
Link: http://hdl.handle.net/10..
 
?
2

OVPSYCH2: A randomized controlled trial of psychological su..:

Frangou, E ; Bertelli, G ; Love, S...
https://discovery.ucl.ac.uk/id/eprint/10129291/1/Love_OVPSYCH2-%20A%20randomized%20controlled%20trial%20of%20psychological%20support%20versus%20standard%20of%20care%20following%20chemotherapy%20for%20ovarian%20cancer_AOP.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
3

Germline and somatic genetic variants in the p53 pathway in..:

Zhang, P ; Kitchen-Smith, I ; Xiong, L...
doi:10.1158/0008-5472.CAN-20-0177.  , 2021
Link: https://doi.org/10.1158/..
 
?
4

Adipocyte-like signature in ovarian cancer minimal residual..:

Artibani, M ; Masuda, K ; Hu, Z...
doi:10.1172/jci.insight.147929.  , 2021
Link: https://doi.org/10.1172/..
 
?
5

Subcellular mRNA Localization Regulates Ribosome Biogenesis..:

Dermit, M ; Dodel, M ; Lee, FCY...
https://discovery.ucl.ac.uk/id/eprint/10115711/1/1-s2.0-S1534580720307966-main.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
6

Weekly platinum-based chemotherapy versus 3-weekly platinum..:

Blagden, SP ; Cook, AD ; Poole, C...
10044/1/80646.  , 2020
Link: http://hdl.handle.net/10..
 
?
7

A Randomized Phase II Trial of Epigenetic Priming with Guad..:

Oza, AM ; Matulonis, UA ; Alvarez Secord, A...
https://discovery.ucl.ac.uk/id/eprint/10092744/1/Guadecitabine%20and%20carboplatin%20in%20ovarian%20cancer.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
8

Effective delivery of Complex Innovative Design (CID) cance..:

Blagden, SP ; Billingham, L ; Brown, LC...
https://discovery.ucl.ac.uk/id/eprint/10089496/1/s41416-019-0653-9.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
9

Weekly platinum-based chemotherapy versus 3-weekly platinum..:

Blagden, SP ; Cook, AD ; Poole, C...
10044/1/79379.  , 2020
Link: http://hdl.handle.net/10..
 
?
10

Weekly platinum-based chemotherapy versus 3-weekly platinum..:

Blagden, SP ; Cook, AD ; Poole, C...
https://discovery.ucl.ac.uk/id/eprint/10104337/11/Cook_1-s2.0-S1470204520302187-main.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
11

Weekly platinum-based chemotherapy versus 3-weekly platinum..:

Blagden, SP ; Cook, AD ; Poole, C...
https://eprints.whiterose.ac.uk/167607/1/Weekly%20platinum-based%20chemotherapy%20versus%203-weekly%20platinum-based%20chemotherapy%20for%20newly%20diagnosed%20ovarian%20cancer%20%28ICON8%29%20qu.pdf.  , 2020
Link: https://eprints.whiteros..
 
?
12

Phase IB Dose Escalation and Expansion Study of AKT Inhibit..:

Blagden, SP ; Hamilton, AL ; Mileshkin, L...
https://discovery.ucl.ac.uk/id/eprint/10065629/3/Blagden_AKTi_Ovarian_Cancer_Manuscript_V5_21Nov18_clean.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
13

A phase Ib dose-finding, pharmacokinetic study of the focal..:

Mak, G ; Soria, J-C ; Blagden, SP...
https://discovery.ucl.ac.uk/id/eprint/10074098/1/s41416-019-0452-3.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
14

Anti-tumour activity of a first-in-class agent NUC-1031 in ..:

Blagden, SP ; Rizzuto, I ; Suppiah, P...
doi:10.1038/s41416-018-0244-1.  , 2018
Link: https://doi.org/10.1038/..
 
?
15

La-related protein 1 (LARP1) binds the mRNA cap, blocking e..:

Lahr, RM ; Fonseca, BD ; Ciotti, GE...
doi:10.7554/eLife.24146.  , 2018
Link: https://doi.org/10.7554/..
 
1-15